P3 Health Partners (NASDAQ:PIII) Coverage Initiated by Analysts at BTIG Research

BTIG Research assumed coverage on shares of P3 Health Partners (NASDAQ:PIIIFree Report) in a report published on Thursday morning, FlyOnTheWall reports. The brokerage issued a buy rating on the stock.

Separately, TD Cowen initiated coverage on P3 Health Partners in a research report on Friday, June 30th. They issued a market perform rating for the company.

View Our Latest Analysis on PIII

P3 Health Partners Price Performance

PIII opened at $1.98 on Thursday. The firm has a market capitalization of $619.10 million, a PE ratio of 0.00 and a beta of 1.23. The company has a debt-to-equity ratio of 16.13, a current ratio of 0.69 and a quick ratio of 0.69. The business’s 50-day moving average is $2.32 and its two-hundred day moving average is $2.16. P3 Health Partners has a 1 year low of $0.70 and a 1 year high of $7.05.

P3 Health Partners (NASDAQ:PIIIGet Free Report) last posted its quarterly earnings data on Monday, August 7th. The company reported ($0.09) EPS for the quarter, topping the consensus estimate of ($0.24) by $0.15. The firm had revenue of $329.09 million during the quarter, compared to analyst estimates of $303.30 million. P3 Health Partners had a negative net margin of 10.92% and a negative return on equity of 2,471.27%. Research analysts anticipate that P3 Health Partners will post -0.96 earnings per share for the current fiscal year.

Insider Activity

In related news, major shareholder Pacific Founders Ugp I. Chicago acquired 90,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 30th. The stock was purchased at an average cost of $1.83 per share, with a total value of $164,700.00. Following the transaction, the insider now directly owns 49,305,442 shares of the company’s stock, valued at approximately $90,228,958.86. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders have purchased a total of 270,000 shares of company stock worth $424,800 over the last 90 days. 17.06% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On P3 Health Partners

Hedge funds have recently made changes to their positions in the company. Marietta Investment Partners LLC purchased a new stake in P3 Health Partners during the 1st quarter valued at about $26,000. Squarepoint Ops LLC purchased a new stake in P3 Health Partners in the fourth quarter valued at approximately $31,000. Walleye Trading LLC purchased a new stake in P3 Health Partners in the second quarter valued at approximately $34,000. State Board of Administration of Florida Retirement System acquired a new position in P3 Health Partners in the 2nd quarter worth approximately $34,000. Finally, SlateStone Wealth LLC purchased a new position in P3 Health Partners during the 2nd quarter worth approximately $39,000. 23.57% of the stock is owned by institutional investors and hedge funds.

About P3 Health Partners

(Get Free Report)

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.

Further Reading

Receive News & Ratings for P3 Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for P3 Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.